Research and innovation

Natural polymers

Our coatings are made of natural polymers. Also known as biopolymers, they are natural materials formed during the life cycle of green plants, animals or bacteria.
 We are innovating by introducing our invisible shields with the development of multifunctional coatings,  for medical devices, consumer products for everyday use, but also as a service to companies. Our patented solutions have antiviral, antimicrobial and anti-inflammatory effects while preventing bacterial resistance. We develop customised, implant-specific coatings that reduce implant-related complications. The solutions are intended for almost any complex surface. 

Research + Innovation

Health research and development is an ongoing process that requires significant commitment and continuous innovation. Spartha Medical offers a personalisable solution that is evaluated for efficacy, safety, and quality prior to use.

Innovation at SPARTHA

The efficacy against a wide range of bacteria (Gram+ and Gram-) have already been demonstrated as well as methicillin-resistant Staphylococcus aureus (MRSA).

Based on supramolecular assembly of natural polymers and their synthesised derivatives (polypeptides and polysaccharides): our coatings can be applied to any kind of surface or geometry in a personalised manner.

The coatings have been applied to many medical grade materials and keep their activity after long term storage and industrial sterilisation methods.

The antimicrobial activity around implants have been demonstrated in vivo together with anti-inflammatory activity.

Spartha medical has 2 Patent Applications

Scientific papers

Collaborative projects

PANBioRA 2018-2021

Personalised And/or Generalised Integrated Biomaterial Risk Assessment. Development of new methods and instruments for biomaterial risk assessment for healthcare industry and for personalised medicine applications.

The project has 17 partners from 11 European countries with an overall budget of 7.992.000 Euros.


European Innovation Council EIC Accelerator project for bringing SPARTHA Medical technologies to clinical trials with a total budget of 4.1 Million Euros (2.4 M€ grant+ 1.7 M€ Equity).

Research Innovation
NOVA 2022-now
EU Horizon Europe funded project: Next Generation Bioactive Coatings with 14 partners from 9 countries with a total budget of 7.5 Million Euros.
SPARTHA Medical is the scientific coordinator.

Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Directorate-General for Communications Networks, Content and Technology. Neither the European Union nor the granting authority can be held responsible for them.